BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2039796)

  • 21. Identification and antimicrobial susceptibility of 250 Bacteriodes fragilis subspecies tested by broth microdilution methods.
    Jones RN; Fuchs PC
    Antimicrob Agents Chemother; 1976 Apr; 9(4):719-21. PubMed ID: 1046357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clindamycin, metronidazole, and chloramphenicol.
    Kasten MJ
    Mayo Clin Proc; 1999 Aug; 74(8):825-33. PubMed ID: 10473362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of four disk diffusion methods for antimicrobic susceptibility tests with anaerobic gram-negative bacilli.
    Barry AL; Fay GD
    Am J Clin Pathol; 1974 May; 61(5):592-8. PubMed ID: 4597112
    [No Abstract]   [Full Text] [Related]  

  • 24. Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic species.
    Pankuch GA; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1112-7. PubMed ID: 16495282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Standardization of antimicrobial disc susceptibility test for anaerobic bacteria.
    Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1976 Dec; 9(3-4):55-62. PubMed ID: 1037535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaerobic infections.
    Dunkle LM
    Pediatr Ann; 1986 Jun; 15(6):446-9. PubMed ID: 3523403
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification and susceptibility patterns of anaerobic bacteria isolated from clinical specimens during a one-year period.
    Rodloff AC; Görtz G; Ponnath H; Hahn H
    Infection; 1984; 12(6):395-401. PubMed ID: 6519812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro susceptibility testing of nonsporing anaerobes to ten antimicrobial agents.
    Rao PS; Shivananda PG
    Indian J Pathol Microbiol; 2000 Apr; 43(2):139-42. PubMed ID: 11217270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaerobic cocci and their resistance patterns to penicillin, cefoxitin, clindamycin and metronidazole: a Bulgarian study.
    Boyanova L; Osmanliev D; Petrov D; Mitov I; Usunova I; Petrov S; Minchev TZ
    Clin Microbiol Infect; 2000 Nov; 6(11):623-4. PubMed ID: 11168069
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro susceptibility testing of nonsporing anaerobes to ten antimicrobial agents.
    Rao PS; Shivananda PG
    Indian J Pathol Microbiol; 2000 Jul; 43(3):281-4. PubMed ID: 11218673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
    Tytgat F
    Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting antibiotic tolerance in anaerobic biofilms associated with oral diseases: Human antimicrobial peptides LL-37 and lactoferricin enhance the antibiotic efficacy of amoxicillin, clindamycin and metronidazole.
    Wuersching SN; Huth KC; Hickel R; Kollmuss M
    Anaerobe; 2021 Oct; 71():102439. PubMed ID: 34454095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European collaborative study of reproducibility of quantitative sensitivity testing of anaerobes.
    King A; Phillips I
    J Antimicrob Chemother; 1988 Apr; 21(4):425-38. PubMed ID: 3378957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activities of fourteen antimicrobial agents against obligately anaerobic bacteria.
    Schaumann R; Ackermann G; Pless B; Claros MC; Goldstein EJ; Rodloff AC
    Int J Antimicrob Agents; 2000 Nov; 16(3):225-32. PubMed ID: 11091040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organisms isolated from dogs and cats with anaerobic infections and susceptibility to selected antimicrobial agents.
    Jang SS; Breher JE; Dabaco LA; Hirsh DC
    J Am Vet Med Assoc; 1997 Jun; 210(11):1610-4. PubMed ID: 9170087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea.
    Lee K; Chong Y; Jeong SH; Xu XS; Kwon OH
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S73-7. PubMed ID: 8953110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The growth-inhibitory properties of meropenem against anaerobes of clinical importance.
    Watt B; Naden M
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():119-24. PubMed ID: 2808203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species.
    Byun JH; Kim M; Lee Y; Lee K; Chong Y
    Ann Lab Med; 2019 Mar; 39(2):190-199. PubMed ID: 30430782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.